Detection and treatment of non-dermal fibrosis
The invention relates to methods for the diagnosis, prognosis, and treatment of non-dermal fibrosis, including lung (or pulmonary) fibrosis.
1. A method for treating a subject having lung fibrosis comprising
administering to a subject in need thereof an anti-cadherin-11 antibody or an antigen-binding fragment thereof in an amount effective to reduce lung fibrosis.
2. The method of claim 1 , wherein lung fibrosis is idiopathic pulmonary fibrosis.
3. The method of claim 2 , wherein idiopathic pulmonary fibrosis is severe idiopathic pulmonary fibrosis.
4. The method of claim 1 , wherein the anti-cadherin-11 antibody or the antigen-binding fragment thereof is administered by inhalation or intranasally.
5. The method of claim 1 , wherein the anti-cadherin-11 antibody or the antigen-binding fragment thereof is administered intraperitoneally.
6. The method of claim 1 , further comprising administering to the subject an immunosuppressant.
7. The method of claim 6 , wherein the immunosuppressant is a steroid.